2017 to 2022 Saw Rise in Cannabis-Related Disorder Encounters in Seniors

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, June 18, 2024 -- From 2017 to 2022, there was an increase in the rates of cannabis-related disorder encounters among U.S. Medicare beneficiaries aged 65 years or older, according to a research letter published online June 18 in JAMA Network Open.

Silvia Perez-Vilar, Ph.D., Pharm.D., from the U.S. Food and Drug Administration in Silver Spring, Maryland, and colleagues characterized trends in health care encounters with cannabis-related disorders among Medicare beneficiaries aged 65 years or older by state or territory cannabis legal status in a cross-sectional study. The eligible population included 55,941,880 unique beneficiaries.

The researchers found that from 2017 through 2022, there was an increase in the rates of health care encounters with cannabis-related disorders, regardless of state or territory cannabis legal status. The greatest rates were seen in states or territories with both adult and medical use legalization, followed by states or territories with medical legalization, and states or territories where cannabis use was illegal (45.4, 41.5, and 27.7 per 10,000 beneficiaries, respectively, in 2022). Across all legalization categories, the greatest increasing trends were seen in nonemergency department outpatient settings.

"Data suggest that increasing rates of health care encounters documenting cannabis-related disorders among older adults might be associated with the type of cannabis legalization," the authors write. "However, differences in cannabis use patterns and perception of risk may influence policy changes and present challenges to causal inference."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-06-19 07:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords